Post-Operative DVT Prophylaxis for Patients with History of Provoked DVT

Risk Assessment and General Recommendations

The American Urological Association recommends that all surgical patients should be assessed for VTE risk, with a history of previous DVT being a significant risk factor that increases the risk approximately six-fold 1
DVT prophylaxis should be considered in all patients undergoing surgical procedures, with the intensity of prophylaxis matching the patient's risk profile 2, 1
For patients with a history of provoked DVT, this previous thrombotic event significantly elevates their risk category, typically placing them in the high or very high-risk category 1, 3

The American College of Chest Physicians recommends LMWH (e.g., enoxaparin) as the first-line agent for post-operative DVT prophylaxis in patients with history of DVT 4, 5
For high-risk patients, including those with previous DVT, the highest prophylactic dose of LMWH should be used 4
Standard dosing for enoxaparin is 40 mg subcutaneously once daily (reduced to 30 mg if creatinine clearance <30 mL/min) 2, 1

Pharmacological prophylaxis should be started 2-12 hours preoperatively and continued for at least 7-10 days postoperatively 4
For patients undergoing major abdominal or pelvic surgery, extended prophylaxis (4 weeks) with LMWH is recommended if they don't have a high risk of bleeding 4, 6

Mechanical methods (intermittent pneumatic compression devices, graduated compression stockings) should be used in conjunction with pharmacological prophylaxis for highest-risk patients, including those with previous DVT 4, 2
Mechanical prophylaxis should not be used as monotherapy except when pharmacological methods are contraindicated due to high bleeding risk 4, 8

In patients with a history of provoked DVT undergoing cancer surgery, extended prophylaxis for 4 weeks is particularly important due to the combined risk factors 4, 8
For patients with renal impairment (CrCl <30 mL/min), dose adjustment of LMWH is required (enoxaparin 30 mg daily) 2, 1
In obese patients (>150 kg), consider increasing the prophylactic dose of enoxaparin to 40 mg subcutaneously every 12 hours 2, 1

Failure to recognize that a history of DVT significantly increases post-operative VTE risk, even if the original DVT was provoked 1, 3
Inadequate duration of prophylaxis, especially after major abdominal or pelvic surgery where extended prophylaxis (4 weeks) has been shown to reduce VTE risk 4, 6
Using mechanical prophylaxis alone in high-risk patients when pharmacological prophylaxis is not contraindicated 4, 8
Not adjusting LMWH dosing for renal function or extreme body weight 2, 1